Nuvation Bio director granted 123,397 stock options
Nuvation Bio Inc. director Robert Mashal received a grant of stock options covering 123,397 shares of Class A common stock at an exercise price of $4.79 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nuvation Bio Inc. director Robert Mashal received a grant of stock options covering 123,397 shares of Class A common stock at an exercise price of $4.79 per share. These options vest 100% on the earlier of May 21, 2026 or the next shareholder annual meeting, contingent on his continuous service. Following the grant, he holds options for 123,397 shares directly, expiring on May 20, 2036.
Insider Trade Summary
Grant/Award: 123,397 shares
Grant/Award
1 txn
Insider
Mashal Robert
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 123,397 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 123,397 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.
Key Figures
Option shares granted: 123,397 shares
Exercise price: $4.79 per share
Underlying shares: 123,397 shares
+4 more
7 metrics
Option shares granted
123,397 shares
Stock Option (Right to Buy) grant to director
Exercise price
$4.79 per share
Conversion or exercise price of option
Underlying shares
123,397 shares
Class A Common Stock underlying the option
Post-grant option holdings
123,397 shares
Total derivative securities following transaction
Vesting percentage
100%
All shares vest in a single tranche
Vesting date trigger
May 21, 2026
One possible full vesting date for the options
Option expiration
May 20, 2036
Expiration date of the stock option grant
Key Terms
Stock Option (Right to Buy), Class A Common Stock, exercise price, vest, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
exercise price financial
"conversion_or_exercise_price: 4.7900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"100% of the shares subject to the option shall vest on the earlier of..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
continuous service financial
"subject to the Reporting Person's continuous service through such applicable vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Nuvation Bio (NUVB) director Robert Mashal receive in this Form 4?
Director Robert Mashal received a stock option grant for 123,397 shares of Nuvation Bio Class A common stock. The options give him the right to buy shares at a fixed price, aligning part of his compensation with future company performance.
What is the exercise price of the Nuvation Bio (NUVB) options granted to Robert Mashal?
The granted options have an exercise price of $4.79 per share. This means Mashal can purchase up to 123,397 shares of Class A common stock at $4.79, regardless of the market price, once the options are vested and exercisable.
When do Robert Mashal’s Nuvation Bio (NUVB) options vest?
All of the options vest 100% on the earlier of May 21, 2026 or the next Nuvation Bio shareholder annual meeting. Vesting is conditioned on Mashal’s continuous service with the company through the applicable vesting date specified in the grant terms.
When do the Nuvation Bio (NUVB) stock options granted to Robert Mashal expire?
The options expire on May 20, 2036. After this expiration date, Mashal can no longer exercise the right to buy Nuvation Bio Class A common stock at the $4.79 exercise price represented by this specific stock option grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates